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 ABSTRACT 
 
TRENDS IN EPIDEMIOLOGY, MORBIDITY PATTERN AND OUTCOME 
OF CHILDREN WITH MEASLES IN A TERTIARY CARE CENTRE IN 
SOUTH INDIA 
BACKGROUND 
     Measles is the most common vaccine preventable disease worldwide accounting for 
38% of disease burden.  In India, measles is a major cause of morbidity and a significant 
contributor to childhood mortality.  India contributes to 47% of global measles death.  
Increase in immunization coverage has led to change in epidemiology of measles. 
AIMS AND OBJECTIVES 
     To study the trends in demographic profile of children presenting with measles, their 
morbidity pattern and clinical outcome attending a tertiary care centre in South India.  To 
determine the course of measles based on various host factors – age, nutritional status, 
socio economic status, immunization status and other host factors in the era of increased 
vaccination coverage. 
METHODOLOGY 
     A prospective descriptive study was done in Institute of Child Health and Hospital for 
Children, Egmore.  The study period was from February 2015 to August 2015.  122 
children with clinical features suggestive of measles and positive Ig M measles antibody 
were included in the study.  The demographic details of the children like age, sex, 
residence, socio economic status,  chronic illness were obtained.  Nutritional status of the 
child was assessed and the presenting symptoms and signs were documented.  
Complications, management required, length of hospital stay and final outcome of 
disease were recorded. 
RESULTS      
     The common age group of children with measles was between 9 months to 2 years 
(32%).  26.3% of children with measles were less than 9 months of age, before the age of 
measles immunization.  Male to female ratio was 1.10:1.  63.9% of cases were from 
urban areas.  Children were from Lower  middle (60.7%) and upper lower (33.6%) socio 
economic class.  32.8% cases occurred in March and 23.8% in April.  35.2% were 
unimmunized, 61.5% had single dose of immunization and 3.3% had 2 doses of 
immunization.  Most common symptoms were fever (96.7%), cough (87.7%), coryza 
(80.3%).  7.4% had severe acute malnutrition and 32% had moderate acute malnutrition.  
26.2% children developed complications.  The most common complication was 
pneumonia (56.3%) followed by febrile seizures (25%) and diarrhea (15.6%).  There was 
a significant association between malnutrition and development of complications ( p 
0.002). Average length of stay was 5.04 days.  88.5% children had complete recovery and 
11.5% left against medical advice.  There was death in the study population due to 
measles and its complications. 
CONCLUSION 
      26.3% of children with measles were less than 9 months old, before the age of 
vaccination. Malnutrition was significantly associated with development of 
complications.  Pneumonia, febrile seizures and diarrhea were the common 
complications.  The overall clinical outcome was good with no mortality.  Measles 
vaccination when given at 6 months (seroconversion rate of 76%) may reduce the 
incidence the measles  till the routine vaccination at 9 months which requires further 
studies.   
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INTRODUCTION 
Measles is a highly infectious disease common in children.  It is caused 
by a virus belonging to the myxoviruses group1.   Worldwide, measles is the 
most common vaccine preventable disease accounting for 38% of disease 
burden3,12.  Though safe and cost effective vaccine is available, measles is one 
of the common causes of death among young children especially in developing 
countries2.  According to WHO, 145700 measles death have been documented 
in the year 2014, 400 children die every day and 16 die every hour3,4.   
Vaccination for measles has led to a 75% drop in measles mortality from 
2000 to 2013 globally5.  Through routine immunization, globally 84% of 
children at 1 year had received atleast a single dose of measles measles 
vaccine.  Inspite of  above measures, measles continues to be a leading cause of 
morbidity and mortality in developing countries due to underlying malnutrition 
and overcrowding.  
In India, measles is a major cause of morbidity and a significant 
contributor to childhood mortality2.  During the year 2011 in India, 33,634 
children had measles which included 56 deaths.  Measles accounts for 3% of 
under 5 mortality in our country7.  India contributes 47% of global measles 
death due to population density and poor immunization coverage11.  Only 71% 
of children receive measles vaccination between 9 to 12 months.  With a 
seroconversion rate of 85% during vaccination at 9 months, only 60% children 
are protected at 9 months.  Remaining 40% children remain susceptible to 
measles which leads to epidemics6. 
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   Problems in eliminating measles are  
 Poor immunization coverage 
 Highly contagious disease 
 Changing epidemiology of measles 
 Need for catch up vaccination 
 
 
The targets set  for 2015 by WHO to eradicate measles are5 
 Improve vaccination coverage -  ≥ 90% receive first dose of measles 
vaccine. 
 Reduce the incidence to 5 cases per million 
 Reduce mortality by  ≥ 95% compared to the year 2000. 
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Measles caused immunosuppression which further leads to 
complications.  The common complications are diarrhea, pneumonia, otitis 
media and neurological complications like encephalitis and febrile convulsions.   
Increase in immunization coverage has led to change in epidemiology of 
measles.   
Measles is caused by a RNA virus belonging to paramyxovirus group.  
It causes exanthematous disease characterized by fever, cough, coryza, 
conjunctivitis, maculopapular rashes and a pathognomic enanthem.  Measles 
has no animal reservoir.  It is exclusively a disease of humans10. 
 
HISTORY 
Measles is an ancient disease with epidemics of measles described 1800 
years ago in the Roman empire and China.  In ancient times, measles was 
frequently confused with other exanthematous diseases like small pox.  Only in 
the 17th century (1629) measles was considered as a separate entity.  In 1690 
Thomas Sydenham clearly described features of measles in English medical 
literature.  During the 17th and 18th century, epidemics involved persons of all 
ages including neonates.  Due to reduction in interval between the epidemics 
there was reduction in age specific incidence of measles.   
Peter Panum, a Danish medical student studied the epidemic of measles 
in Faroe Islands in 1846.  This laid the foundation for the scientific knowledge 
about measles.  Panum from the study inferred that the disease spread only 
through human-to-human transmission via the respiratory route and the 
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incubation period is around 14 days and once infected people acquire lifelong 
immunity10. 
Koplik in 1896 described the enanthem of measles which is now 
considered the pathognomonic sign of measles.  Tissue culture vaccines both 
inactivated and attenuated were developed and came in to general used from 
1963. 
MEASLES VIRUS 
Measles is relatively a large virus 120-150nm in diameter with 
symmetry of helical capsid.  It has a RNA genome.  It belongs to the genus 
Morbillivirus who are  members of the family Paramyxoviridae.  Measles virus 
does not have neuraminidase activity like other members of paramyxovirus 
family but has hemagglutination property.   The virus is composed of inner 
helical nucleocapsid and outer  lipoprotein envelope.  The envelope has three 
proteins – F protein involved in fusion of virus, H protein for hemagglutination 
and M protein for maturation of the virus10.  
 
5 
 
 
 
The measles virus can be grown on human or monkey kidney and 
human amnion cultures which can be used for primary isolation of the virus.  
These isolates can be grown on continuous cell lines and in the amniotic sac of 
hen’s eggs.  In measles infection both nuclear and cytoplasmic inclusion bodies 
are seen.  Measles virus is heat labile and is readily inactivated by heat, uv 
light, ether, chloroform and extremes of pH.  The virus can be stabilized by 
magnesium sulphate.  After stabilization, the vaccine can be stored at -70˚C for 
5 or more years. 
Measles virus is antigenically related to canine distemper virus and 
bovine rinderpest virus.  All measles strains have antigenic homogeneity.  
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Cross reactivity is present among the genus Morbillivirus but not in other 
members of the family Paramyxoviridae.   
 
EPIDEMIOLOGICAL DETERMINANTS 
AGENT FACTORS  
 AGENT: RNA paramyxovirus with one serotype. 
 SOURCE OF INFECTION: A case of measles.  There are no carriers 
and no animal reservoir. 
 SPREAD OF INFECTION: Infection is spread through the respiratory 
route.  Greatest infectivity occurs during the prodromal stage of the 
illness.  Transmission is through aerosolized droplets. Portal of entry is 
through nose and conjunctiva.  90% of susceptible individuals when 
exposed to a case of measles, acquire the disease. 
 COMMUNICABILITY: Children with measles are highly infectious 
during the prodromal phase and eruption of rashes. Infectivity declines 
rapidly after the development of rashes.  The infective period 4 days 
prior and 4 days after the onset of rash.  Isolation of  the child for 1 
week after the onset of rash will prevent transmission of virus. 
 SECONDARY ATTACK RATE:  Measles virus has only one 
antigenic subtype. So, infection confers lifelong immunity. Hence, if a 
child presents with secondary attack then there is a error in diagnosis 
either initially or during the second illness 
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HOST FACTORS 
 AGE: In developing countries measles affects children from 6 
months of age.  The common age of illness is between 6 months and 
3 years.  In developed countries the age of acquiring the disease is 
above 5 years 
 SEX: Male and female are equally affected in measles.  Though the 
incidence is same among both the sexes, the complication rates were 
higher in men when compared to women. 
 IMMUNITY: Measles can occur at any age. No child is immune to 
the disease if they have not acquired immunity either through active 
or passive immunization.  One attack give lifelong immunity.  
During infancy, upto 6 months of age, maternal measles antibodies 
provide passive immunity to the baby and may persist upto 9 months 
of age.   
 NUTRITION: Malnourished children have severe form of measles 
with complications and contribute significantly to mortality.  They 
are 400 times higher risk of mortality when compared to normal 
children.  Malnourished children shed the virus for longer duration 
and hence contribute to the spread of infection to other children.  
Measles itself can precipitate malnutrition in health child after 
infection. 
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ENVIRONMENTAL FACTORS 
Measles can spread in any part of the year. In tropical countries, the 
epidemics occur during hot and dry seasons (January to April).  In temperate 
countries, it occurs in winter as people remain indoor which leads to crowding.  
In countries with low socioeconomic status, the disease affects children of 
younger age. 
PATHOLOGY 
Measles virus multiplies within the respiratory tract epithelium and 
casuing inflammation and necrosis.  Lymphocytes infiltrate at the site of 
necrosis.  There are multinucleated giant cells due to cell fusion which are of 
two types namely Warthin-Finkeldey cells and epithelial giant cells1. 
The Warthin-Finkeldey cells are present in the reticuloendothelial 
system like tonsils, adenoids, peyer patches, appendix, lymph nodes and 
spleen.  They cotain 100 or more nuclei.  Both cytoplasmic and nuclear 
eosinophilic inclusion bodies are seen.  The epithelial giant cells are present in 
the respiratory epithelium and also over other epithelial surfaces.   
The disease has 4 phases – incubation, prodromal phase, exanthematous 
phase and recovery.  During incubation phase, the virus enters lymph node. 
Primary viremia occurs. Prodromal phase starts after secondary viremia.  
During this period necrosis and giant cells formation occur.  Necrosis occurs by 
multiplication of the virus and fusion of the cells.  Antibody production starts 
after the onset of rash.  The virus also affects the CD4 T cells resulting in 
immunosuppression. 
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COURSE OF MEASLES VIRUS INFECTION 
DAY EVENT 
0 Measles virus enters through the nasopharyngeal epithelium and replicates 
1-2 Virus reaches regional lymph nodes 
2-3 Primary Viremia 
3-5 Virus multiplies at respiratory epithelium, reticuloendothelial system and sites of spread 
5-7 Secondary Viremia 
7-11 Involvement of skin, respiratory system, CNS  and other organs  
11-14 Virus is present in respiratory tract, skin, CNS and other organs 
15-17 Viral load decreases and diminishes 
 
CLINICAL MANIFESTATIONS 
The natural history of measles has three phases – prodromal, eruptive 
and recovery phase.  The incubation period of measles is 10 days (9-11days).  
Children are usually asymptomatic during the first 10 days of infection 
 
PRODROMAL PHASE 
The prodromal phase of measles lasts for 4 days from day 10 to day 14 
of infection.  Children  have the characteristic features of fever, malaise, cough, 
coryza and conjunctivitis.  The symptoms worsen over a period of 2 to 4 days. 
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Fever spikes rise upto 103 F.  The nasal symptoms are similar to any other 
respiratory infection like common cold and pharyngitis.  Children have 
sneezing,  running nose and redness of eyes.  The conjunctivitis is associated 
with lacrimation and photophobia.  Cough will be severe and disturbing and 
have a brassy quality. 
 
      
 
 
 
 
One or two days prior to the onset of rash, koplik spots appear which are 
the pathognomonic sign of measles.  They appear as bluish white spots on a red 
base in the buccal mucosa and even in the conjunctiva and the vaginal mucosa.  
They first appear in the buccal mucosa opposite the lower first and second 
molars and later involve other parts of the mucosa.  They are the size of pin 
heads 1mm but sometimes coalesce to form large ones.   
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ERUPTIVE PHASE 
The eruptive phase starts around day 14 of infection.  The prodromal 
symptoms like cough, fever, koplik spots peak during the appearance of rash 
and later subside after the onset of rash.  The rashes first appear behind the ear 
and over the forehead beneath the hairline.  Then they spread in centrifugal 
fashion.  In 3 days, the rashes appear in face, neck, trunk, upper and lower 
extremities in the same order1.   
 
 
 
 
 
 
 
The exanthem is an erythematous maculopapular rash. They are discrete 
in the extremities whereas they become confluent in the face and upper trunk.  
By day 3 or 4 after the appearance, the rash starts resolving in the same 
centrifugal course as it appeared.  During this stage, there is desquamation of 
skin in the confluent areas and brownish discolouration of skin.  Fever, 
conjunctivitis and cough subside by 3rd day of onset of rash.  Persistence of 
fever, respiratory symptoms beyond this period suggests secondary bacterial 
infection and complications.  Children can also have vomiting, diarrhea, 
pharyngitis and laryngitis. 
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RECOVERY PHASE 
Post measles even a healthy child will lose weight and may be week for 
varying periods.  Some children may develop complications due to 
immunosuppression following measles infection and the underlying nutritional 
deficiency in the child.  Growth will be affected and the child can have chronic 
diarrhea and reactivation of pulmonary tuberculosis2.    
ATYPICAL MEASLES 
Subclinical and inapparent measles infection occurs in some vaccinated 
children and in some infants who receive the measles antibodies passively.  
They do not shed the virus and not  involve in the transmission of the disease.  
Some children who have received the formalin inactivated measles vaccine had 
developed severe form of atypical measles.  Children had high grade fever with 
headache, the rashes became petechial and appeared in a centripetal fashion.  
The atypical measles was associated with complications like pneumonia and 
pleural effusion.  The pathogenesis postulated for atypical measles is the 
formation of circulating immune complex due to abnormal immune response  
to vaccination1. 
LABORATORY DIAGNOSIS 
Measles is often diagnosed clinically by the presence of characteristic 
features.  During the prodromal phase, multinucleated giant cells can be 
demonstrated form the nasal secretion by Giemsa stain.  The antigen can also 
be detected from the secretion by immunofluoresence technique.  Virus can be 
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isolated from nasal, throat, conjunctival secretions, blood and urine during the 
prodromal phase.  
Serological studies are the commonly used to confirm the diagnosis of 
measles.  Demonstration of Measles specific IgM antibodies can be done using 
ELISA.  The IgM antibodies become positive 1 to 2 days after the onset of rash 
and remain in the serum for one month.  Serologic confirmation can also be 
done by demonstrating four fold rise in Ig G titres from sample taken during 
the acute illness and 2-4 weeks later.  Serological studies are done to only 
confirm the diagnosis and they do not affect the management. 
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DIFFERENTIAL DIAGNOSIS 
 Rubella 
 Adenoviruses 
 Enteroviruses 
 Infectious mononucleosis 
 Exanthem subitum 
 Erythema infectiosum 
 Mycoplasma pneumonia 
 Group A streptococcus 
 Kawasaki syndrome 
 Drug eruptions 
COMPLICATIONS 
Measles damages the respiratory system and suppresses the immune 
system which leads to complications.  In developing countries several other 
factors like malnutrition, overcrowding and poor immunization coverage12.  
Complications and death are more common in young children (especially < 1 
year of age) and adults (>20 years of age). 
In overcrowded places, children get inoculated with large doses of viral 
load from the reservoir.  Malnutrition causes poor immune response which 
adds to the prevailing immunosuppression caused by the disease perse leading 
to increased rates of morbidity and mortality.   
Measles causes a decrease in the serum retinol concentrations.  Children 
with low retinol levels have higher risk of developing complications and death 
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when compared to normal children.  Immunocompromised persons when 
infected with measles  have severe complications.  58% develop pneumonia 
and 20% have encephalitis. 
PNEUMONIA 
Pneumonia is the major cause contributing to mortality in children with 
measles.  Pneumonia can develop either by direct viral infection or by 
secondary bacterial infection.  Measles virus causes giant cell pneumonia.  
Radiograph in viral pneumonia is characterized by diffuse patchy infiltrates and 
hyperinflated lung fields 
     The bacterial pathogens causing pneumonia are  
 Streptococcus pneumonia 
 Hemophilus influenza  
  Staphylococcus aureus.  
 In either form of pneumonia the death occurs due to the development of 
bronchiolitis obliterans. 
OTHER RESPIRATORY MANIFESTATIONS 
 Croup 
 Tracheitis 
 Bronchitis 
 Pharyngitis  
 Laryngitis 
 Otitis media – most common complication associated with measles.   
 Mastoiditis 
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 Sinusitis 
 Retropharyngeal abscess 
 Reactivation of pulmonary tuberculosis in a child infected with TB. 
GASTROINTESTINAL MANIFESTATIONS 
 Diarrhea with dehydration 
 Vomiting  
 Appendicitis – lymphoid hyperplasia obliterates the lumen of appendix 
The epithelium of gastrointestinal tract shows giant cells 
CNS MANIFESTATIONS 
Febrile seizures have been reported in 3% of children with measles 
Encephalitis 
Children developing encephalitis following measles infection have a 
poor outcome1,12,13.  Encephalitis develops during the period of eruptive phase 
and some cases have been reported to manifest in the prodromal phase.  
Encephalitis is commonly reported in adolescents than young children.The 
pathogenesis behind encephalitis is unclear.  Post infectious autoimmune 
damage has been postulated to be the cause of encephalitis 
      The clinical manifestations of encephalitis are  
 Seizures (56%) 
 Lethargy (46%) 
 Coma (28%) 
 Irritability (26%) 
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Other manifestations include Cerebellar ataxia, myelitis, retrobulbar 
neuritis and hemiplegia.  Long term sequelae  are mental retardation, deafness 
and motor weakness. 
CSF examination will reveal elevated mononuclear cells with mild 
elevation of protein and normal glucose.  Mortality in measles encephalitis is 
15% and 20-40% children develop long term sequelae.   
In immunocompromised persons, encephalitis occurs due to direct 
invasion of the virus in brain tissue.  Subacute measles encephalitis occurs in 
children with AIDS, malignancy and immunosuppresion.  These children will 
present between 1-10 months with seizures, stupor and coma, finally leading to 
death. 
CARDIAC MANIFESTATIONS 
 Myocarditis 
 Pericarditis 
OTHER MANIFESTATIONS 
 Hemorrhagic measles also know as Black measles presents with 
hemorrhagic skin eruption and bleeding from nose, mouth and GI tract.  
The pathogenesis most like is said to be disseminated intravascular 
coagulation. 
 Thrombocytopenic purpura 
 Acute glomerulonephritis 
 Corneal ulcer 
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 Pregnancy – Measles in pregnancy increases the morbidity and 
mortality in both mother and children.  Pneumonia complicates pregnant 
mother.  Spontaneous abortions, still births and premature delivery 
occurs.  Congenital malformations in children have been reported.  
Congenital measles infection is severe and results in 30% mortality.  
Infants born to mother with measles are given passive immunization at 
birth. 
TREATMENT 
Measles management involves only supportive care.  There is no 
specific anti viral therapy for measles. Supportive care is aimed at maintaining 
normal physiological status of the patient.  Antipyretics are given for fever.  
Pneumonia is treated with oxygen, airway humidification, antibiotics and in 
rare circumstances ventilator support.  Diarrhea is managed with oral 
rehydration solution.  There is no use of prophylactic antibiotic therapy in 
measles. Ribavirin with IV gamma globulin have been tried in 
immunocompromised persons infected with measles and they have high 
mortality rate. 
VITAMIN A ADMINISTRATION 
In developing countries, children have low serum retinol level which is 
further aggravated by measles infection leading to corneal ulcer and blindness.  
Studies have shown a inverse relationship between serum retinol level and 
complications due to measles.  Treatment of measles patients with vitamin A 
has shown a decrease in morbidity and mortality2. 
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In India, measles patient receive two doses of vitamin A, on the day of 
diagnosis and the next day .  Children having vitamin A deficiency are given an 
additional third dose at 4 to 6 weeks. 
AGE VITAMIN A DOSAGE 
< 6 months 50,000 IU 
6-11 months 1,00,000 IU 
≥ 12 months 2,00,000 IU 
 
PROGNOSIS 
In developing countries, prognosis is determined by host factors like 
age, socio economic status, nutritional status and immunization coverage.  
With widespread usage of immunization, the incidence and mortality rates have 
dropped significantly.  Majority of the children have uncomplicated measles.  
Pneumonia and encephalitis contribute to mortality in children. 
PREVENTION 
Children susceptible to measles infection should be prevented from 
contact with a case of measles.  This can be achieved by isolation of children 
with measles during the infective period.  Active and passive immunization are 
available for prevention against measles.  As per WHO, Immunization 
coverage of 90% and above nationally is aimed to combat measles. 
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MEASLES VACCINATION 
 VACCINE: Live attenuated vaccine formulated from Edmonston 
Zagreb stain is used in India.  It is a lyophilized vaccine and is 
reconstituted with distilled water.  It has no preservative.  0.5ml of 
vaccine contains 1000 infective units.  Freeze dried vaccines can be 
stored for 2 years.  Once reconstituted the vaccine must be used within 4 
hours.  Reconstituted vaccines can be stored at 2 to 8˚C as the vaccine is 
heat labile and is sensitive to sunlight.  The vaccine at 1 hour, losses 
50% of its potency at 20˚C and 100% of its potency at 37˚C7. 
 
 
 
 
 
 
 
 
 AGE: In India, first dose of measles vaccination is administered at 9 
months age.  In Tamil Nadu, a second dose of measles vaccination is 
administered along with DPT  and OPV  booster between 19-24 months.  
In case of an outbreak of measles, the first dose can be given at 6 
months followed by a second dose at 9 months with a minimum interval 
of 4 weeks between two doses. 
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 ADMINISTRATION: Subcutaneous administration over the right 
upper arm 
 REACTIONS: 15 to 20% of vaccinated children develop mild measles 
like illness.  It is transient and the children are not infective 
 IMMUNITY: Measles vaccine has a seroconversion rate of 90% when 
administered at 9 months and 99% when administered after 1 year. 
Antibodies are produced in 2 weeks of vaccination. 
 CONTRAINDICATIONS: Immunocompromised children, HIV in 
advanced stage, malignancy, children on high dose steroids and 
antimetabolites.  In asymptomatic susceptible HIV positive children in 
early stages of disease, the vaccine can be given as early as 6 months 
followed by two more doses at 9 months and 16 months 
 
IMMUNOGLOBULIN: 
Susceptible children exposed to a case of measles can be prevented from 
getting the infection by administration of immunoglobulin early  in the 
incubation period preferably 3 to 4 days from exposure.  The dose of 
immunoglobulin is 0.25ml per kg body weight.  Live measles vaccine are given 
8 to 12 weeks after passive immunization. Immunoglobulin are also 
administered to neonate born to mother with measles to prevent congenital 
measles7. 
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REVIEW OF LITERATURE 
Alphonsuset al12 studied the clinical profile of children with measles in 
a secondary health care institution in Nigeria.  77  children  with measles were 
studied over a period of 4 years.  Diagnosis is made clinically. 3.1% of  
hospital admissions were measles.  47.8% of children were between 13 and 24 
months.  18.1% were less than 9 months old.  Only 22% of cases were 
vaccinated against measles.  Cases were reported mostly during the dry season 
(80.5%).  The two most common complications were bronchopneumonia 
(55.1%) and diarrhea with dehydration (13.0%). 
Anis-ur-Rehman et al13 studied the clinical outcome of patients with 
measles who were hospitalized  with complications.  136 patients admitted in 
the hospital with complications of measles were included in the study. A 
thorough history, physical examination, immunization status and nutritional 
status were recorded and clinical outcome was compared with the above 
parameters.  60.3% of patients were male. Children immunized with measles 
were 57.3%.   Malnourished children (71.35%) had a longer hospital stay (> 5 
days).  The common complications were pneumonia ( 39.7%) and diarrhea 
(38.2%).  The number of children who died were 7 and the common cause for 
death was encephalitis (57.1%) 
Ariyasriwatanaet al14 studied the clinical presentations of persons with 
measles and its complications and compared the severity of complications with 
host factors like age, nutritional status and vaccination status.  156 children 
with measles who were admitted to Queen Sirikit National Institute of Child 
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Health were studied.  Male to female ratio was 1.56:1.  Median age of 
presentation was 1.5 years and mode was 8 months.  Children below 2 years of 
age were59%; below 1 year were 40% and below 9 months were 23.9%.  Only 
44% of children were vaccinated against measles.  91.4% of children below 1 
year of age were not vaccinated.  12.4% had mild PEM, 4.8% had moderate 
PEM, 2.1% had sever PEM.  9% of children had chronic diseases.  The triad of 
cough, rash and coryza was found in 92.3% of cases.  Pneumonia (62.2%) and 
diarrhea (38.1%) were the common complications.  One child died of severe 
Pneumonia and ARDS.  Diarrhea was more common among young children.   
Raoteet al15 in Mumbai studied the clinical profile of children 
hospitalized with measles for a period of one year.  150 children were taken up 
for the study.  Children less than 1 year were 28%; between 1 to 3 years were 
60%; 3 to 5 years were 8.6% and 5 to 7 years were 2.6%.  Male to female ratio 
was 1.2:1.  Grade I-II  malnutrition was present in 36.6% children and grade 
III-IV PEM  was present in 9.9% of children.  More than half of the children 
had complications of which 15% had multisystem involvement.  The 
complications were 50% - respiratory, 17.3% - nutritional detoriation, 14.6% - 
gastrointestinal and neurological and 1.3% - cardiac.  Pneumonia, bronchitis, 
activation of TB, otitis and miliary tuberculosis were the respiratory 
complications.  Encephalitis, convulsions and meningitis were the CNS 
complications.  The incidence of complications and multisystem involvement 
were higher in children less than 1 year.  Well nourished children had no 
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complications whereas PEM  children had mild to severe complications 
depending on the grade of PEM. 
Aurangazeb B et al16 in Pakistan studied the clinical outcome of 
measles in children who were admitted with complications.  It was a cross 
sectional study over a period of one year.  205 children with measles 
complications were included in the study.  Details regarding demographic data, 
immunization and physical examination were recorded.  Majority of  children 
were male (61.5%).  The mean age of presentation was 46.1 months. Of the 
205 children, 57% were vaccinated against measles.  Malnourished Children 
(71.2%) had a longer length of stay at hospital ( p=0.010).  The common 
complications were pneumonia (40.0%) and diarrhea (38.5%).  Seven children 
in the study died.  Statistically significant association was found between 
mortality and younger age (p=0.04), unvaccinated children (p=0.04) and 
children with encephalitis (p=0.00001). 
Baba Usman Ahmaduet al17 in Nigeria measured the maternal measles 
antibody titres in infants at seven months of age.  Infants become susceptible to 
measles infection before the time of routine vaccination (9 months).  This was 
attributable to low levels of maternal measles antibodies in children at 9 
months.  136 children with age of seven months were studied.  The children 
were term at birth, had no history of contact with measles or had a history 
suggestive of measles.  Children enrolled were tested for maternal measles 
antibody titre (MMA) using enzyme linked immunosorbent assay.  Male 
children were 50.7% and female 49.3% and ratio of male to female was 1.03:1.  
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Of the 136 infants studied, 125 (91.9%)  infants had unprotective levels of 
maternal measles antibody at the age of seven months.   The possible 
explanation for the decreased levels of  MMA is that mothers in this era have a 
decreased amount of measles antibodies compared to prevaccination era.  In 
present era, mothers having measles vaccine induced MMA  are higher than 
measles virus induced MMA.  Therefore children born to measles vaccinated 
mothers will get less amount of  MMA  by placental transfer and hence have 
low unprotective titres at 7 months of age.  This accounts for the changing 
epidemiology of measles with more number of children getting measles within 
9 months age (the timing of vaccination of measles).  The possibility of 
explanation could not be confirmed as measles immunization in mother or 
history of measles in mother could not be obtained. 
Jin D et al18 studied the respiratory complications of measles children 
admitted in PICU.  17 children were studied between the age group of 2 
months to 10 years.  All the children required mechanical ventilation.  14 cases 
developed ARDS, 6 went in for tension pneumothorax and 3 developed 
bronchitis.  7 children died and 7 had complete recovery.  Mortality was higher 
if measles children required PICU support and prognosis was poor.  Laryngitis 
took longer time for recovery.   
Abramson et al19 studied the complications of measles in children 
required intensive care.  237 measles children were hospitalized of which 15 
children developed complications requiring PICU care.  All the 15 children 
required mechanical ventilation.  Seven children developed ARDS, three had 
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spontaneous pneumothorax, two developed empyema.  CNS complication 
namely encephalopathy was found in 7 children, five had sepsis.  Four patients 
went in for long term sequelae.  Four children died and the cause of death in all 
the four was ARDS.  Measles children requiring intensive care had a higher 
rate of mortality and long term sequelae.   
Sinha DP et al20 studied the prevalence of measles in a West Bengal 
village for 5 years.  Majority of the cases occurred between the months of May 
and august.  Children were between 2 to 6 years of age and 91.5% of children 
were below 7 years of age.  181 children were enrolled.  Two children with 
kwarshiorkar died of measles.  There was no mortality among marasmic 
children.  Clinical diagnosis of measles was difficult in malnourished children 
when compared to well nourished children. 
Alwar AJ et al21 studied 7447 cases of measles in an infectious disease 
hospital in Nairobi.  The mortality rate was 17.5 per 1000 children.  Among the 
death, 43.51% were below 1 year of age.  Malnourished children had a longer 
length of hospital stay and higher rate of mortality when compared to healthy 
children. 
Olatian AE et al22 studied the seroprevalence of measles virus in 
children aged 0-8 months and children aged 9-23 months.  The overall 
prevalence was 21.2%.  6.5% of children were between 0-8 months and 61.6% 
of children were between 9-23 months.   Female children had a higher 
prevalence when compared to male.  Child’s vaccination status was 
significantly associated with prevalence of measles virus. 
27 
 
Aaby P et al23 studied the effect of early vaccination for measles and 
survival of the children.  Two doses of measles vaccine was given one at  4-6 
months and second dose at 9 months of age.  They concluded that mortality can 
be reduced in developing countries by vaccinating children at younger age in 
the presence of maternal measles antibodies, using 2 doses one at 4-6months 
and second dose at 9-12 months 
Ariyasriwatana C et al24 studied the seroconversion rate of measles in 
infants immunized at 9 months of age.  70% of children vaccinated at 9 months 
of age had a seroconversion for measles.  The antibody titres were significantly 
low at 18 months of age.  Hence, a second dose of  vaccination at 15 months of 
age boosts the antibody titres  and protects the children from acquiring 
infection 
Johnson CE et al25 studied the measles antibody titres  in children born 
to mother who have vaccine induced immunity against measles.  74% of 
children vaccinated at 6 month of age developed seroconversion – neutralizing 
antibodies whereas children immunized at 15 months of age had 100% 
seroconversion.  Children vaccinated at 6 months of age when given a booster 
at 15 months of age, developed 100% seroconversion.   
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RATIONALE 
 Measles is a major cause of morbidity and mortality among the vaccine 
preventable diseases 
 Increase in immunization coverage has led to change in the 
epidemiology of  measles 
 Prognosis of measles is determined largely by host factors 
 Studies are lacking regarding clinic-epidemiologic profile of measles 
after introduction of two doses of measles vaccination 
 
INSTITUE OF CHILD HEALTH – STATISTICS ON MEASLES 
CASES AND DEATHS 
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AIMS AND OBJECTIVES 
 To study the trends in demographic profile of children presenting with 
measles, their morbidity pattern and clinical outcome attending a 
tertiary care centre in South India 
 To determine the course of measles based on various factor – age, 
nutritional status, socio economic status, immunization status and 
other host factors in the era of increased vaccination coverage. 
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METHODOLOGY 
 
STUDY CENTRE 
 Institute of Child Health and Hospital for Children, Egmore, Chennai. 
 
STUDY DESIGN 
 Descriptive study 
 
STUDY POPULATION 
 Children upto 12 years of age attending the Children’s Hospital (ICH & 
HC) in Egmore 
 
SAMPLE SIZE 
 Total number of sample  : 122 children 
 Sample size was calculated using the following formula 
                                    N = 4pq/d2 
           Where, 
N = Sample size 
p = Prevalence  
q = Complement of p (1-p) 
d =Relative Precision (20%) 
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145 children presented 
with features suggestive 
of Mealses
122  children Positive 
for Ig M measles 
antibody included in 
the study
23 children Negative 
for Ig M measles 
antibody exlcuded 
from the study
Ig M Measles 
antibody by ELISA
 
 
 
 
The prevalence for sample size calculation is derived from the study 
conducted by RaoteGh et al15 where 53% of children presented with 
complications of measles. 
 
 
  
Prevalence Estimated sample size 
53 99 
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DURATION OF THE STUDY 
 February 2015 to August 2015 
 
INCLUSION CRITERIA 
All children ≤ 12 years of age presenting with maculopapular rash 
suggestive of measles with any of other features like 
 Fever 
 Cough 
 Coryza 
 Conjunctivitis 
With laboratory confirmation of Measles by identifying measles 
specific Ig M antibodies using Enzyme Linked Immunosorbent Assay. 
 
EXCLUSION CRITERIA 
 Parents and guardians not willing to give consent for the study. 
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STUDY MANOEUVRE 
 Children presenting to the hospital with clinical features suggestive 
of measles are enrolled in the study after getting informed consent 
from the parents. 
 Blood samples (2 ml)  are taken after consent from parents and are 
sent to Kings Institute, Guindy for serologic confirmation of measles.  
Ig M ELISA  for measles  is done.       
 Children who are confirmed as measles by laboratory investigation 
(122 children)  are included in the study.  Children who presented 
with measles like illness and are negative for Ig M Measles 
antibodies are excluded from the study (23 children). 
 Basic demographic details like age, sex, place of residence are 
collected in the proforma 
 Children’s place of residence has been recorded as coming from 
urban or rural areas 
 Socio economic status of the Child’s family is arrived using 
Modified Kuppusami Scale.  They were categorized as belonging to 
one of the following – upper, upper middle, lower middle, upper 
lower and lower. 
 Immunisation details of the child has been collected by viewing 
previous vaccination cards and treatment records. 
 Children if suffering from any chronic illness , the details of the same 
are recorded 
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 The following complaints of the child has been obtained namely, 
fever, cough, coryza, conjunctivitis, day of onset of rash, diarrhea, 
seizures and other complaints 
 Height, weight and mid arm circumference ( 1 to 5 years ) of the 
children are recorded and the nutritional status was obtained by using 
WHO growth charts till 5 years of age and IAP charts above 5 years 
of age.  The children are categorized in one of the following – severe 
acute malnutrition, moderate acute malnutrition, chronic malnutrition 
and no malnutrition 
 Head to foot examination of the child has been done and signs like 
rashes, koplik spots, anemia and lymph adenopathy are noted. 
 Children  are examined thoroughly two times a day for emergence of 
new symptoms and signs or for the resolution of presenting 
signs/symptoms and complications, course of the disease in the 
hospital throughout their stay. 
 The physiological status of the child was ascertained by measuring 
the heart rate, respiratory rate and perfusion and are labeled as either 
stable or unstable physiological status 
 Unstable children are further categorized as respiratory distress or 
shock 
 Complications of the child if present are recorded under  the 
following – otitis media, pneumonia, diarrhea, febrile seizures, 
encephalitis and others 
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 Details of supportive management like like oxygen, IV fluids, 
antibiotics  and others are recorded 
 Length of stay of children in the hospital is obtained.  The final 
outcome is recorded as one of the following parameters – complete 
recovery, disability, death and leaving against medical advice.  
 Parents are counseled about nutritional supplementation, routine 
vaccination  and preventive measures against spread of infection to 
other children.  Follow up of the  children are done at  vaccine 
preventable  diseases opd, ICH & HC, Egmore. 
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DATA ANALYSIS 
145 Children presented to the vaccine preventable diseases outpatient 
department of ICH &HC  with clinical features suggestive of measles (fever, 
cough, coryza, conjunctivitis and maculopapular rash).  Of the 145 children, 
122 children were confirmed as measles by serological examination namely Ig 
M Measles antibody by ELISA.  The remaining 23 children who were negative 
for Ig M measles antibody were excluded from the study. 
Data was collected using the proforma.  Data was entered in excel sheet 
and analysis was done using statistical package for social sciences (SPSS) 20 
version.  Results of the descriptive data  are presented in percentages.  Chi 
Square test was used to compare the study variables with complications.  P 
value of less than 0.05 was considered significant. 
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Observation 
Age distribution of children with measles 
 
 
Among the 122 children with measles, 10.7% (13 children) were ≤ 6 
months, 15.6% (19 children) were between 7 to 9 months,  32% (39 children) 
were between 9 months to 2 years, 18% (22 children) were between 2 to 5 
years, 21.3% (26 children) were between 5 to 10 years and 2.5% (3 children) 
were more than 10 years 
 
 
 
Age Frequency Percent 
<=6 months 13 10.7 
6mths to 9 mths 19 15.6 
9mths- 2yrs 39 32.0 
2yrs-5yrs 22 18.0 
5yrs-10yrs 26 21.3 
> 10yrs 3 2.5 
Total 122 100.0 
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Distribution of age group 
 
      The common age group of measles was found to be between 9 months 
to 2 years (32%).  26.3% of children had measles before the age of 
immunization which is 9 months 
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Sex distribution of children with measles 
 
Sex Frequency Percent 
Male 64 52.4 
Female 58 47.6 
Total 122 100.0 
 
      The study population had 64 male(52.4%) and 58 female (47.6%) 
children.  The male: female ratio is 1.10:1 
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Place of residence of study population 
 
 
 
Children presenting with measles from urban area was 63.9 % (78 
children) and 36.1% of  children were from rural areas around Chennai. 
 
 
Distribution of Place of residence of study group 
  
63.9
0
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Urban
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Residence Frequency Percent 
Urban 78 63.9 
Rural 44 36.1 
Total 122 100.0 
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Socioeconomic status of the study population 
Socioeconomic status Frequency Percent 
Upper 0 0 
Upper middle 7 5.7 
Lower Middle 74 60.7 
Upper Lower 41 33.6 
Lower 0 0 
Total 122 100.0 
  
Lower middle class contributed majority of the socio economic status 
with 74 children (60.7%) in that group.  7 children (5.7%) were from upper 
middle and the second majority was upper lower with 41 children (33.6%).  No 
children belonged to the upper and lower socio economic group. 
 
Distribution of socioeconomic status of children with measles 
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Month of presentation of children with measles 
 
 
 
 
 
 
 
 
 
 
      Majority of measles children were admitted during march (40 children – 
32.8%) and april (29 children – 23.8%).  In February 23 children with measles 
were admitted (18.9%).  The rest of the admissions in other months were 5 
children (4.1%) in may, 8 children in june (6.6%), 7 children in july (5.7%) and 
10 children in august (8.2%). 
 
18.9
32.8
23.8
4.1 6.6 5.7
8.2
0
5
10
15
20
25
30
35
Feb Mar Apr May June July August
PE
R
C
E
N
T
MONTH
Month Frequency Percent 
Feb 23 18.9 
Mar 40 32.8 
Apr 29 23.8 
May 5 4.1 
June 8 6.6 
July 7 5.7 
August 10 8.2 
Total 122 100.0 
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Immunization status of the study population 
Immunization status Frequency Percent 
Single Dose 75 61.5 
Two Dose 4 3.3 
Not Immunized 43 35.2 
Total 122 100.0 
 
 
Unimmunized children with measles were 35.2% (43 children).  75 children 
with measles had 1 dose of measles vaccination (61.5%) and 4 children (3.3%) 
who had two doses of immunization developed measles. 
 
 
 
 
 
 
 
 
 
Distribution of measles immunization status of study population 
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Measles in children with chronic illness 
 
Chronic illness Frequency Percent 
present 10 8.2 
 absent 112 91.8 
Total 122 100.0 
 
 
Of the 122 children with measles, 10 children had chronic illness 
(8.2%).  The chronic illness were seizure disorder, congenital heart disease, 
nephrotic syndrome and AIDS. 
 
 
Distribution of Chronic illness in children with measles 
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Fever in children with measles 
 
 
Among the 122 children who had measles, 118 children  had fever (96.7%). 
 
 
 
Proportion of fever in the study population 
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Fever Frequency Percent 
present 118 96.7 
absent 4 3.3 
Total 122 100.0 
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Cough in children with measles 
 
 
 
107 children (87.7%)  of 122 in the study population presented with 
cough. 
 
 
 
Proportion of cough in study population 
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Cough Frequency Percent 
present 107 87.7 
absent 15 12.3 
Total 122 100.0 
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Coryza in children with measles 
 
      The number children who presented with coryza as one of the symptom 
were 98 children (80.3%). 
 
 
Proportion of coryza in children with measles 
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Coryza Frequency Percent 
present 98 80.3 
absent 24 19.7 
Total 122 100.0 
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Conjunctivitis in children with measles 
 
Conjunctivitis was present in 57 children (46.7%) who were admitted 
with measles. 
 
 
Distribution of conjunctivitis in study population 
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Conjunctivitis Frequency Percent 
present 57 46.7 
absent 65 53.3 
Total 122 100.0 
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Day of onset of rash in children with measles 
 
Day of Rash Frequency Percent 
Day 3 39 32.0 
 Day 4 67 54.9 
Day 5 16 13.1 
Total 122 100.0 
 
      Of the 122 children with measles, rashes were present on day 3 of fever 
in 39 children (32%), day 4 of fever in 67 children (54.9%) and day 5 of fever 
in 16 children (13.1%). 
 
 
Distribution of day of onset of rash in the study population 
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Diarrhea in children with measles 
 
Diarrhea Frequency Percent 
present 
 
22 
 
18.0 
absent 
 
100 82.0 
Total 122 100.0 
 
22 children (18%) had complaints of diarrhea during admission out of 
the 122 cases of measles. 
 
Proportion of children with diarrhea in the study group 
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Seizures in children with measles 
 
Seizures Frequency Percent 
Present 8 6.6 
Absent 114 93.4 
Total 122 100.0 
 
 8 children (6.6%) who were admitted for measles had seizures. 
 
 
 
 
 
 
 
 
 
 
 
Proportion of seizures in children with measles 
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Nutrition status of children with measles 
 
Nutrition Frequency Percent 
Severe Acute malnutrition 9 7.4 
Moderate Acute malnutrition 39 32.0 
Chronic malnutrition 3 2.4 
No malnutrition 71 58.2 
Total 122 100.0 
 
Severe acute malnutrition was present in 9 children (7.4%). 71 children 
(58.2%)  with measles had no malnutrition.  Moderate acute malnutrition was 
present in 39 children (32.0%) and chronic malnutrition in 3 children (2.5%). 
 
Distribution of nutritional status in children with measles 
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Koplik spots in children with measles 
 
 
Koplik spots, the pathognomonic sign of measles was seen in 20 
children (16.4%). 
 
 
 
 
 
 
 
 
 
Proportion of children with koplik spots 
 
 
  
Koplik spots Frequency Percent 
present 20 16.4 
absent 102 83.6 
Total 122 100.0 
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Anemia in study population 
 
Anemia Frequency Percent 
present 37 30.3 
absent 85 69.7 
Total 122 100.0 
 
Among the 122 children, 37 children (30.3%) had pallor.   
 
 
 
 
 
 
 
 
 
 
Proportion of children with anemia 
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Children with Lymphadenopathy in the study population 
 
Lymphadenopathy Frequency Percent 
Present  10 8.2 
Absent 112 91.8 
Total 122 100.0 
 
      10 children (8.2%) among the 122 children had lymphadenopathy may 
be due to secondary bacterial infection and complications. 
 
 
Proportion of children with lymphadenopathy 
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Physiological status of children in study group 
 
     Among the 122 children, 99 children (81.1%) had a normal physiological 
status and the 23 children (18.9%) had unstable physiological status in the form 
of respiratory distress and shock. 
 
 
Children with unstable physiological status 
 
 
 
 
Physiological status Frequency Percent 
Stable 99 81.1 
Unstable 23 18.9 
Total 122 100.0 
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Children with unstable physiological status 
 
Among the 23 children who had unstable physiological status 14 
children (60.8%) had respiratory distress due to pneumonia while 9 children 
(39.2%) had shock as a result of various complications. 
 
 
  
Unstable physiological 
status Frequency Percent 
Respiratory  distress 14 60.8 
Shock  9 
 
39.2 
Total 23 100 
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Complications in children with measles 
 
Among the 122 children, 32 children (26.2%) developed complications 
in the form of pneumonia, diarrhea, febrile seizures and encephalopathy.  90 
children (73.8%) had and uneventful course of measles. 
 
Proportion of children with complications 
  
Complications Frequency Percent 
present 32 26.2 
 
absent 
 
90 73.8 
Total 122 100.0 
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 Proportion of various complications in measles children 
 
  Among the children who developed complication, majority developed 
Pneumonia (18 children – 56.3%).  8 children(25%)  had febrile seizures.  
Diarrhea was present in 5 children (15.6%) and one child developed 
encephalopathy. 
 
 
 
  
Complications Frequency Percent 
Pneumonia 18 56.3 
Diarrhea 5 15.6 
Encephalopathy 1 3.1 
Febrile seizures 8 25 
Total 32 100 
60 
 
15.6
20.5
23.8
13.9
0
5
10
15
20
25
Oxygen IV Fluids Antibiotics Others
PE
RC
EN
T
MANAGEMENT
Management required for children with measles 
Management Frequency Percent 
Oxygen 19 15.6 
IV Fluids 25 20.5 
Antibiotics 29 23.8 
Others 17 13.9 
 
19 children (15.6%) pneumonia  required treatment with oxygen, 20.5% 
with shock and dehydration  received IV fluids, 23.8% were treated with  
antibiotics for shock and febrile convulsions and 13.9% required other 
management like anti epileptic drugs and zinc.   
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Length of stay in study population 
 
 
 N Minimum Maximum Mean Std. Deviation 
Length of Stay 122 2 11 5.04 1.783 
 
 
The mean length of hospital stay of 122 children was 5.04 days.  The 
minimum duration of stay was 2 days and maximum was 11 days. 
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Outcome of children admitted with measles 
Outcome Frequency Percent 
Complete Recovery 108 88.5 
LAMA 14 11.5 
Total 122 100.0 
 
Of the 122 children, 108 children (88.5%) completely recovered.  14 
children (11.5%) went against medical advice.  No death occurred during the 
study period due to measles and its complications. 
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Crosstabulation of Age of children and complications 
 
 
 
 
 
 
 
 
 
 
P value 0.144 
     Of the 32 children who developed complications 13 children were between 
9 months and 2 years.  7 children < 9 months developed complications. 
 
  
Age 
complications 
Total 
Yes No 
 
<=6 months 2 11 13 
6mths to 9 mths 5 14 19 
9mths- 2yrs 13 26 39 
2yrs-5yrs 9 13 22 
5yrs-10yrs 3 23 26 
> 10yrs 0 3 3 
Total 32 90 122 
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Cross tabulation of sex of children and complications 
 
Sex 
complications 
Total 
Yes No 
 
Male 18 46 64 
Female 14 44 58 
Total 32 90 122 
 
P value 0.717 
     Of the 64 male children admitted with measles, 18 developed complications.  
Among female children 14 developed complications out of 58 children. 
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Crosstabulation of residence of children and complications 
 
 
 
 
 
 
 
 
 
P value 0.056 
Children with place of residence in urban area had complication in 16 
children 78 children  and 16  children from rural residence developed 
complications among 44 children. 
 
  
Residence 
complications 
Total 
Yes No 
Urban 16 62 78 
Rural 16 28 44 
Total 32 90 122 
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Crosstabulation of socioeconomic status of children and complications 
Socioeconomic 
status 
complications 
Total 
Yes No 
 
Upper 
Upper Middle 
0 
1 
0 
6 
0 
7 
Lower Middle 18 56 74 
Upper Lower 
Lower 
13 
0 
28 
0 
41 
0 
Total 32 90 122 
 
P value 0.524 
18 children from lower middle class had complications.  In  upper lower 
class 13 developed complications of 28 children and 1 had complications from 
upper middle class. 
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Crosstabulation of immunization status and complications 
Immunization status 
complications 
Total 
Yes No 
 
 
Single Dose 
 
21 
 
54 
 
75 
Two Dose 0 4 4 
Not Immunized 11 32 43 
Total 32 90 122 
 
P value 0.460 
21 children out of 75 children with single dose of measles vaccination 
developed measles whereas in unimmunized group 11 of 43 children developed 
complications. No complications were seen in 4 children who were immunized 
with two doses of measles vaccination.  
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Crosstabulation of chronic illness and complications 
 
 
 
 
 
 
 
P value 0.302 
10 children with chronic illness like seizure disorder, congenital heart 
disease, nephrotic syndrome and AIDS  had measles.  4 among them developed 
complications. 
 
 
 
  
Chronic illness 
complications 
Total 
Yes No 
 
Yes 4 6 10 
No 28 84 112 
Total 32 90 122 
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Crosstabulation of Nutritional status of children and complications 
 
Nutrition 
complications 
Total 
Yes No 
 
 
Severe Acute malnutrition 
 
5 
 
4 
 
9 
Moderate Acute malnutrition 15 24 39 
Chronic malnutrition 2 1 3 
No 10 61 71 
Total 32 90 122 
 
P value 0.002 
Among the 122 children with measles, 51 children had malnutrition and 
complications were higher in children with co existing malnutrition.  The p 
value was statistically significant (p value 0.002). 
 
  
70 
 
Association of complications and length of hospital stay 
 
Children who had complications (32 children) had a longer duration of 
hospital stay with mean of 7.28 days.  Children without measles had a mean 
hospital stay of 4.24 days with a standard deviation of 1.020. 
 
 
 
 
 
 
 
 
 
 
 
  
 
LOS 
complications N Mean Std. Deviation Std. Error Mean 
Yes 32 7.28 1.550 .274 
No 90 4.24 1.020 .108 
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DISCUSSION 
Measles is the most common vaccine preventable disease world wide.  
In developing countries measles still contributes significantly to morbidity and 
mortality in children.  In India, measles accounts for 5% of under 5 mortality 
and contributes to 47% of global measles death7,11.  The main problem our 
country is facing in eliminating the disease is changing epidemiologic pattern, 
poor immunization coverage and need for catch up immunization.  Only 71% 
of children in our country receive vaccination between 9 months to 12 months 
Changing epidemiologic trends has led to more children getting measles 
less than 1 year of age as a result of low protective maternal measles antibody 
titre in children  as said by Baba Usman Ahmadu et al17.  In studies done 
previously on measles, the diagnosis of measles is made clinically like children 
presenting with maculopapular rash, cough, conjunctivitis, coryza and koplik 
spots.  In our study, children diagnosed clinically as measles are confirmed by 
laboratory diagnosis namely Ig M measles antibody. 
122 children were included in the study.  Age of the children with 
measles in our study  ranged from  4 months to 12 years.  26.7% of children 
were less than 9 months of age, the age at which first dose of measles 
vaccination is given in our country.  Among them 10.7% of children were less 
than 6 months of age, where maternal measles antibodies is said to be 
protective against measles.  Majority of the children were between 9 months 
and 2 years (32%). 
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COMPARISON OF AGE GROUP OF MEASLES IN DIFFERENT STUDIES 
AGE 
GROUP 
Our 
Study 
Raote et 
al15 
Ariyasriwatana C 
et al14 
Alphonsus N 
et al12 
Anis-ur-
Rehman 
et al13 
< 9 months 26.7% 
28% 
(<1 
year) 
23.9% 18.1% 
20.5% 
(<1 year) 
9 mths to 2 
years 
32% 
60%     
( 1 to 2 
years) 
35.1% 
81.9% 
41.9% (1 
– 5 years 
2 to 5 
years 
18% 8.6% 
41% 
>5 years 23.8% 2.6% 37.4% 
 
In developing countries, one fourth of children are acquiring measles 
before the age of vaccination.  The age distribution was similar to the study 
done by Ariyasriwtanaet al14 in Thailand, but proportion of children < 6 months 
with measles is not documented in the study. 
In our study, the male to female ratio of measles was 1.10:1.  52.4% of 
male children and 47.6% of female children developed the disease.  There was 
a slight male preponderance which was similar to other studies done on 
measles. 
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COMPARISON OF SEX DISTRIBUTION OF MEASLES IN STUDIES 
SEX 
DISTRIBTUION 
Our 
study 
Raote 
et al15 
Ariyasriwatana 
C et al14 
Alphonsus 
N et al12 
Aurangazeb 
et al16 
Anis-ur-
Rehman 
et al13 
Male:Female 1.10:1 1.2:1 1.56:1 1.03:1 1.59:1 1.5:1 
 
63.9% of children with measles were from urban area.  36.1% were from 
rural area.  Overcrowding, migration and easy accessibility to health care may 
have contributed to higher proportion of cases from urban areas.  The result 
was similar to study done by Alphonsuset al12 where 67.5% of children were 
from urban areas.  Majority of the children were from lower middle class 
(60.7%) while the remaining belong to upper lower (33.6%) and upper middle 
class (5.7%). 
The study was done over a period of seven months from February 2015 
to August 2015.  March month had the most number of cases (32.8%).  75.5% 
of cases were between the month of February and April.  This was similar to 
the study done by Alphonsus C et al12 where 80.5% of measles cases occurred 
during the dry season. 
35.2% of  children with measles were unimmunized.  72 children who 
presented with measles had a single dose of immunization which may be due to 
poor seroconversion rate of measles vaccine when administered at 9 months.  4 
children with measles had 2 doses of immunization.  
10 children with chronic illness like seizure disorder, congenital heart 
disease, nephrotic syndrome and retroviral disease developed measles which 
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contributed to 8.2% of measles cases.  In the study by Ariyasriwatana C et al14 
in Thailand, 9% of children had underlying diseases. 
 
SYMPTOM ANALYSIS  
SYMPTOM FREQUENCY PERCENTAGE 
Fever 118 96.7% 
Cough 107 87.7% 
Coryza 98 80.3% 
Conjunctivitis 57 46.7% 
Day of onset of rash 
 Day 3 
 Day 4 
 Day 5 
 
39 
67 
16 
 
32% 
54.9% 
13.1% 
Diarrhea 22 18% 
Seizures 8 6.6% 
 
The common presentations of children with measles from above 
tabulation are fever (96.7%), cough (87.7%), coryza (80.3%) and conjunctivitis 
(46.7%).  Majority of children developed rashes on day 4 of onset of fever 
(54.9%) while the rest developed on day 3(32%) and day 5 (13.1%).  Diarrhea 
and seizures were present in 22 (18%) and 8 (6.6%) children respectively.  In 
the study done by Ariyasriwatana C et al14 rash, cough and coryza was found in 
92.3% of cases similar to our study.   
Malnutrition was present in 41.8% of children with measles.  7.4% had 
severe acute malnutrition, 32% had moderate acute malnutrition and 2.4% had 
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chronic malnutrition.  The percentage of children with malnutrition in our study 
is less when compared to other studies ( Raote et al15, Aurangazeb  et al16  and 
Anis-ur-Rehman et al13) 
 
COMPARISON OF MALNUTRITION IN MEASLES AMONG STUDY GROUPS 
NUTRITIONAL 
STATUS 
Our 
study 
Raote 
et al15 
Aurangazeb 
B et al16 
Ariyasriwatana 
C et al14 
Anis-ur-
Rehman 
et al13 
Malnutrition 
 Mild 
 Moderate 
 Severe 
 Chronic 
 
 
32% 
7.4% 
2.4% 
 
 
36.6% 
9.9% 
 
 
71.2% 
12.4% 
4.8% 
2.1% 
7.3% 
23.5% 
40.4% 
No Malnutrition 58.2% 53.3% 28.8% 66% 28.6% 
 
Malnourished children had higher incidence of complication when 
compared to well nourished children which is statistically significant                  
(p  value 0.002) 
20 children (16.4%) in the study population had koplik spots.  This 
observation is higher when compared to study done by Anis-ur-Rehmanet al13 
(10%).  30.3% children had anemia and 8.2% had lymphadenopathy.  Among 
the 122 children, 23 presented with unstable physiological status like 
respiratory distress and shock due to complications like pneumonia, diarrhea 
and acute CNS infection. 
26.2% of children admitted with measles developed complications in 
our study which was contributed by pneumonia (56.3%), diarrhea (15.6%), 
febrile seizures (25%) and encephalopathy (3.1%).  The proportion of children 
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with complications were nearly half when compared to the study done by 
Raoteet al15 in India during the initial years of introduction of measles vaccine. 
  
COMPLICATIONS OF MEASLES AMONG VARIOUS STUDIES 
COMPLICATIONS Our study 
Raote et 
al15 
Anis-
ur-
Rehma
n et al13 
Alphonsu
s N et al12 
Aurangaze
b B et al15 
Ariyasriwatan
a C et  al14 
Pneumonia 56.3% 43% 39.7% 55.1% 40% 62.2% 
Diarrhoea 15.6% 14.6% 37.5% 13% 38.5% 38.1% 
Febrile 
convulsions 25% 2.6%  5.8%   
Encephalitis 3.1% 8% 8.8%    
 
Pneumonia (56.3%) was the most common complication in our study 
which was similar compared to other studies.  But incidence of diarrhea 
(15.6%) was lower when compared to previous studies.  25% of children 
developed febrile seizures and it was the second most common complication 
following measles.  Only one child had encephalopathy. 
The mean length of stay of children admitted with measles was 5 days 
ranging from 2 to 11 days.  Children with complications and malnutrition had a 
longer length of hospital stay when compared to other children similar to the 
study done by Anis-ur-Rehmanet al13.  
Of the 122 children, 108 children completely recovered (88.5%)  while 
14 children left against medical advice whose final outcome could not be 
ascertained.  There was no death among the children admitted with measles, the 
reason may be increased health care facilities and low incidence of children 
developing encephalitis compared to previous studies.  
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CONCLUSION 
Measles is the most common vaccine preventable disease presenting to 
our hospital.  Even after introduction of two doses of measles vaccination, there 
is no decline in measles admission in our hospital with an average of 200 
children admitted each year.  There is a shift in epidemiology of measles with 
more amount of children affected less than the immunization age (9 months).  
In our study 26.3% of children with measles were less than 9 months of age.  
This may be attributable to poor maternal measles antibody levels in the 
children.  58.3% of children were less than 2 years and complications are 
higher in young children. 
Measles vaccination when given at 6 months has a seroconversion rate 
of 76%. When given a vaccination at 6 months, children with low maternal 
measles antibodies may be protected till the next vaccination at 9 months.  The 
incidence of measles in children between 6 to 9 months may be decreased 
which requires further studies. 
Male and females are almost equally acquired measles.  Higher 
admissions are from urban areas.  Higher proportion of cases were children 
with single dose of measles vaccination may be due to poor seroconversion at 9 
months.  Majority of cases occurred during the months of February, March and 
April.   
Malnutrition was present in 41.8% children and was associated with 
higher rates of complications which was statistically significant (p 0.002) and 
longer length of stay in hospital.  Pneumonia was the most complication 
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(56.3%).  Second most complication was febrile seizures contributing to 25% 
followed by diarrhea (15.6%). The average length of stay in hospital was 5 
days.  All the children had complete recovery.  There was no mortality in the 
study population.  The overall outcome of study population was good. 
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LIMITATIONS 
The study was done in children’s hospital, Egmore.  Only children who 
presented to this hospital were studied.  Children presenting to other peripheral 
hospitals in the same demographic area were not studied.  The study was done 
for 7 months from February to August.  The occurrence of disease over a 
period of 1 year could not be analysed.   
Children from rural areas could have been treated at peripheral health 
centres.  Source of infection of children with measles was not analysed.  The 
final outcome of some children who went against medical advice could not be 
ascertained.    Since the study group represented only few areas of the region, 
the results could be generalized to whole population. 
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INFORMATION SHEET 
Place of study: INSTITUTE OF CHILD HEALTH AND HOSPITAL FOR 
CHILDREN, EGMORE 
Name of Investigator : DR. BHARANIKUMAR R 
Name of Participant   age:   sex:  
Hospital No:      
Study title :Trends in epidemiology, morbidity pattern and outcome of children 
with measles in a tertiary care centre in South India 
 
• We are conducting a study on Trends in epidemiology, morbidity pattern 
and outcome of children with measles in a tertiary care centre in South 
India 
 Measles ranks first among vaccine preventable disease burden 
 In India, measles is a major cause of childhood morbidity and mortality 
due to underlying malnutrition and crowding 
 We are conducting a study in ICH & HC regarding trends in measles 
epidemiology, various morbidity pattern and clinical outcome of 
affected children 
We request you to participate in the study 
• The purpose of this study is to study the demographic profile and 
complications in children presenting with measles. 
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• The privacy of the patients in the research will be maintained throughout the 
study. Inthe event of any publication or presentation resulting from the 
research, no personallyidentifiable information will be shared. 
• Taking part in this study is voluntary. You are free to decide whether to 
participate inthis study or to withdraw at any time; your decision will not result 
in any loss ofbenefits to which you are otherwise entitled. 
• The results of the special study may be intimated to you at the end of the 
study periodor during the study. 
 
 
 
Signature of investigator                                         Signature of parent/guardian 
Date: 
 
 
 
 
 
 
 
 
87 
 
 
88 
 
  
89 
 
INFORMED CONSENT FORM 
Study place: INSTITUTE OF CHILD HEALTH AND HOSPITAL FOR 
CHILDREN 
Title of the study: Trends in epidemiology, morbidity pattern and outcome of 
children with measles in a tertiary care centre in South India 
Name of the investigator  :  DR. BHARANIKUMAR R    
Name of the Participant:  Age:   Sex: 
Hospital number:    
1. I have read and understood this consent form and the information provided 
to me regarding the participation in the study.  
2. I have had the consent document explained to me.  
3. I have been explained about the nature of the study.  
4. I have been explained about my rights and responsibilities by the 
investigator.  
5. I have informed the investigator of all the treatments I am taking or have 
taken in the past including any native (alternative) treatment.  
6. I have been advised about the risks associated with my participation in this 
study.* 
7. I agree to cooperate with the investigator and I will inform him/her 
immediately if I suffer unusual symptoms. * 
8. I have not participated in any research study in the past. 
10. I am aware of the fact that I can opt out of the study at any time without 
having to give any reason and this will not affect my future treatment in this 
hospital. * 
11. I am also aware that the investigator may terminate my participation in the 
study at any time, for any reason, without my consent. * 
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12. I hereby give permission to the investigators to release the information 
obtained from me as result of participation in this study to the sponsors, 
regulatory authorities, Govt. agencies, and IEC. I understand that they are 
publicly presented.  
13. I have understand that  my  identity will be kept confidential if my data are 
publicly presented  
14. I have had my questions answered to my satisfaction.  
15. I have decided to be in the research study.  
I am aware that if I have any question during this study, I should contact the 
investigator. By signing  
this consent form I attest that the information given in this document has been 
clearly explained to me  
and understood by me, I will be given a copy of this consent document. For 
adult participants:  
Name and signature / thumb impression of the participant /parents/guardian  
Name _________________________ Signature_________________ 
Date________________  
Name and Signature of impartial witness:  
Name _________________________ Signature_________________ 
Date________________ 
Name and Signature of the investigator or his representative obtaining consent:  
Name _________________________ Signature_________________ 
Date________________  
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PROFORMA 
 
TRENDS IN EPIDEMIOLOGY, MORBIDITY PATTERN AND OUTCOME 
OF CHILDREN WITH MEASLES IN A TERTIARY CARE CENTRE IN 
SOUTH INDIA 
 
Serial Number:                                             Ip No:                                     Date: 
 
1.Name:                                                
2.     Age:       1) ≤ 6 months 
                     2) 6 to 9 months 
                     3) 9 months to 2 years 
                     4) 2 to 5 years 
                     5) 5 to 10 years 
                     6) > 10 years 
3. Sex: 1) male       2) female                                                                         
4. Residence:  1) urban       2) rural 
5. Socioeconomic Status:  1) Upper 
                                             2) Upper middle 
                                             3) Lower middle 
                                             4) Upper lower 
                                             5) Lower 
6. Month of the year:   1) February     2) March     3) April     4) May     5) June                
6) July  7) August 
 7. Immunization Status:        1) Immunized with single dose of measles vaccine 
                                           2) Immunized with two doses of measles vaccine 
                                           3) Not Immunized 
8. AnyChronic illness in the child?   1) Yes   2) No 
9. If Yes, specify  ___________________ 
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COMPLAINTS 
 
 
ANTHROPOMETRY: 
11. Weight: 
12. Height: 
13. Mid arm circumference (1 to 5 years): 
14. Nutritional Status:  1) Severe Acute Malnutrition 
                                       2) Moderate Acute Malnutrition 
                                       3) Chronic Malnutrition 
                                       4) No Malnutrition 
 
GENERAL EXAMINATION 
15. 
S. No SIGN 1) PRESENT / 2) ABSENT 
a) Rashes  
b) Koplik spots  
c) Anemia  
e) Lymph adenopathy  
f) Others (specify)  
 
 
  
10. S.NO SYMPTOMS 1) PRESENT/  2) ABSENT 
1) Fever  
2) Cough  
3) Coryza  
4) Conjunctivitis  
5) Day of onset of rash 
1) Day 1 
2) Day 3 
3) Day 3 
6) Diarrhoea  
7) Seizures  
8) Others (specify)  
95 
 
VITAL SIGNS 
16. Pulse rate                                    17. Respiratory rate 
18. Blood pressure                            19. Temperature 
20. Physiological status  1) Stable     2) Unstable 
21. If unstable,     1) Respiratory distress     2) Shock     3) Apnea/Cardiac arrest 
 
SYSTEMIC EXAMINATION: 
22. Cardiovascular system: 
23. Respiratory system: 
24. Abdomen: 
25. Central Nervous system: 
26. Complications:   1) present     2) absent 
27. If present :     1) otitis media 
                            2) Pneumonia 
                            3) Diarrhoea 
                            4) Encephalopathy 
                            5) Febrile seizures 
                            6) Others (specify) 
27. Treatment: 
 
S.No INTERVENTION YES/NO 
1 Oxygen support  
2 IV Fluids  
3 Antibiotics  
4 Others (specify)  
 
28. Duration of hospital stay: 
 
29. Outcome:    1) Complete recovery 
                       2) Disability 
                       3) Death 
                       4) LAMA 
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